1. NVP-BEZ235 or JAKi Treatment leads to decreased survival of examined GBM and BBC cells
   Neftali Vazquez et al, 2021, Cancer Treatment and Research Communications CrossRef
2. Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells
   Fadime Çetin et al, 2023, Medical Oncology CrossRef
3. Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: Mechanisms and therapeutic potential
   Hadi Alizadeh et al, 2025, European Journal of Pharmacology CrossRef
4. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways
   Bihui Li et al, 2022, Frontiers in Pharmacology CrossRef
5. Cancer stem cell markers interplay with chemoresistance in triple negative breast cancer: A therapeutic perspective
   Sethu Parvathy Pillai Babu et al, 2022, Bulletin du Cancer CrossRef
6. Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
   Stefan Holzhauser et al, 2021, Frontiers in Oncology CrossRef
7. Anticancer Action of Xiaoxianxiong Tang in Non-Small Cell Lung Cancer by Pharmacological Analysis and Experimental Validation
   Rongzhen Ding et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor
   Yen-Hsiang Huang et al, 2024, International Journal of Molecular Sciences CrossRef
9. The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatment
   Christophe Glorieux et al, 2025, Biochemical Pharmacology CrossRef
10. Diclofenac Sensitizes Signet Ring Cell Gastric Carcinoma Cells to Cisplatin by Activating Autophagy and Inhibition of Survival Signal Pathways
    Nang Lae Lae Phoo et al, 2022, International Journal of Molecular Sciences CrossRef